Showing 641 - 660 results of 754 for search '"Pharmacokinetics"', query time: 0.04s Refine Results
  1. 641

    Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia by Andrew H. Han, Caroline R. Burroughs, Evan P. Falgoust, Jamal Hasoon, Grace Hunt, Juyeon Kakazu, Tim Lee, Adam M. Kaye, Alan D. Kaye, Latha Ganti

    Published 2023-01-01
    “…Its safety and efficacy, mechanism of action, pharmacokinetic parameters, and relative lack of rebound and withdrawal effects render suvorexant a reliable choice for the treatment of insomnia.…”
    Get full text
    Article
  2. 642

    Probing the role of Coniferin and Tetrahydrocurcumin from Traditional Chinese medicine against PSAT1 in early-stage ovarian cancer: An in silico study. by Jia Zhang, Shalesh Gangwar, Nagmi Bano, Shaban Ahmad, Mohammed S Alqahtani, Khalid Raza

    Published 2025-01-01
    “…The inhibitory effects of Coniferin and Tetrahydrocurcumin compounds were evaluated with the Pharmacokinetic studies and compared with the standard values, which resulted in an utter performance against each descriptor of the QikProp and performed the Molecular Interaction Fingerprints that resulted in the most interaction residues with counts were 4GLY, 4ASN, 4HIE, 4SER, 4THR, 3ARG and many more. …”
    Get full text
    Article
  3. 643

    Role of Cyclosporine in Crohn's Disease by CN Williams

    Published 1990-01-01
    “…Once the response is present, the drug may be switched to the oral route, and a pharmacokinetic profile performed. The drug may need to be given three or four times a day in some Crohn's disease patients. …”
    Get full text
    Article
  4. 644

    Identifying natural inhibitors against FUS protein in dementia through machine learning, molecular docking, and dynamics simulation by Darwin Li

    Published 2025-02-01
    “…Originating from medicinal plants, these compounds are not only structurally compatible with the target protein but also adhere to pharmacokinetic profiles suitable for drug development, including optimal molecular weight and LogP values conducive to blood-brain barrier penetration. …”
    Get full text
    Article
  5. 645

    Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation by Austin Clark, Brendan Tate, Bretton Urban, Ryan Schroeder, Sonja Gennuso, Shahab Ahmadzadeh, David McGregor, Brook Girma, Sahar Shekoohi, Alan D. Kaye

    Published 2023-07-01
    “…This investigation reviews the pharmacokinetic and pharmacodynamic effects of bupropion and its mechanisms of action and interactions with other drugs. …”
    Get full text
    Article
  6. 646

    Ethnomedicinal, Pharmacological, and Phytochemical Overview of Diplazium esculentum by Abhishek Singh

    Published 2025-01-01
    “…Mechanistic insights delve into molecular pathways elucidating the interactions of D. esculentum bioactives with cellular targets and signalling cascades. Furthermore pharmacokinetic considerations shed light on the absorption distribution metabolism and excretion ADME profiles of its constituents providing critical insights into their bioavailability and pharmacological efficacy. …”
    Get full text
    Article
  7. 647

    Rapid, Validated UPLC-MS/MS Method for Determination of Glibenclamide in Rat Plasma by Mohd Aftab Alam, Fahad Ibrahim Al-Jenoobi, Abdullah Mohammed Al-Mohizea

    Published 2018-01-01
    “…The method was successfully implemented for pharmacokinetic investigations (in-house data).…”
    Get full text
    Article
  8. 648

    Development and Validation of an LC-MS/MS Method and Comparison with a GC-MS Method to Measure Phenytoin in Human Brain Dialysate, Blood, and Saliva by Raphael Hösli, Stefan König, Stefan F. Mühlebach

    Published 2018-01-01
    “…For larger sample numbers as in pharmacokinetic/pharmacodynamic studies and for bedside as well as routine analyses, the LC-MS/MS method offers significant advantages over the GC-MS method.…”
    Get full text
    Article
  9. 649

    Unlocking Dabrafenib’s Potential: A Quality by Design (QBD) Journey to Enhance Permeation and Oral Bioavailability through Nanosponge Formulation by Konda Sri Chaya Reddy, Darna Bhikshapathi, Jaini Pavan Kumar

    Published 2025-01-01
    “…Zeta sizer, SEM, spectrum analysis, in vitro release, and pharmacokinetic tests were among the other analyses that further validated the optimization. …”
    Get full text
    Article
  10. 650

    In Vivo Evaluation of 1-O-(4-(2-Fluoroethyl-Carbamoyloxymethyl)-2-Nitrophenyl)-O-β-D-Glucopyronuronate: A Positron Emission Tomographic Tracer for Imaging β-Glucuronidase Activity... by Iněs F. Antunes, Hidde J. Haisma, Philip H. Elsinga, Aren van Waarde, Antoon T.M. Willemsen, Rudi A. Dierckx, Erik F.J. de Vries

    Published 2012-01-01
    “…Ex vivo biodistribution of [ 18 F]FEAnGA was conducted in healthy rats. PET imaging and pharmacokinetic modeling were performed in Wistar rats bearing C6 tumors of different sizes and sterile inflammation. …”
    Get full text
    Article
  11. 651

    Variable Absorption of Clavulanic Acid After an Oral Dose of 25 mg/kg of Clavubactin® and Synulox® in Healthy Cats by Tom B. Vree, Eric Dammers, Eri van Duuren

    Published 2002-01-01
    “…The aims of this investigation were to calculate the pharmacokinetic parameters and to identify parameters, based on individual plasma concentration-time curves of amoxicillin and clavulanic acid in cats, that may govern the observed differences in absorption of both drugs. …”
    Get full text
    Article
  12. 652

    On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients by T.A. Morozova

    Published 2023-03-01
    “…The authors provide rationale for the selection of an optimal anti-inflammatory drug underpinned by the clinical trial results, pharmacodynamic and pharmacokinetic  parameters of NSAIDs of a new generation. …”
    Get full text
    Article
  13. 653
  14. 654

    Effects of macrolide antibiotics on blood inflammatory mediators and organ damage markers in lipopolysaccharide-induced pulmonary damage rats by Ayşe Er, Enver Yazar

    “…Area under the concentration time curve (AUC<sub>0-24</sub>), maximal concentration in plasma or serum (C<sub>max</sub>) and time to reach Cmax (t<sub>max</sub>) values were determined by pharmacokinetic computer program.<p> <b>Results:</b> Macrolide antibiotics increased serum tumor necrosis factor &#945; and plasma 13, 14-dihydro-15-keto-prostaglandin F<sub>2&#945;</sub> levels.…”
    Get full text
    Article
  15. 655

    Penetration of linezolid and tedizolid in cerebrospinal fluid of mouse and impact of blood–brain barrier disruption by Marin Lahouati, Mélanie Oudart, Philippe Alzieu, Candice Chapouly, Antoine Petitcollin, Fabien Xuereb

    Published 2025-01-01
    “…All the plasma and CSF samples were analyzed with a validated UPLC‐MS/MS method. Pharmacokinetic parameters were calculated using a non‐compartmental approach based on the free drug concentration. …”
    Get full text
    Article
  16. 656
  17. 657

    5-Fluorouracil-β-Cyclodextrin conjugates:Linker strategies to enhance the anticancer efficacy and reduce the side effects by Liangliang Hu, Ting Meng, Davies Marabada, Zhichao Jin, Qing Huang, Shijie Wei, Zhizhong Wang

    Published 2025-03-01
    “…Additionally, the conjugate exhibited reduced cytotoxicity towards normal colon epithelial cells. Pharmacokinetic analyses revealed that 5-FUSA-β-CD and 5-FUBA-β-CD were eliminated slowly and their half-lives were longer than that of free 5-FU. …”
    Get full text
    Article
  18. 658

    Simultaneous Quantification of Aspirin, Its Metabolite Salicylic Acid, and Salvianolic Acid B in Human Plasma Using UPLC-MS/MS by Weiyi Cao, Hezhi Yao, Zhenzhen Qian, Yi Wu, Shuge Wang, Rui Li, Rui Gao

    Published 2021-01-01
    “…The validated method was successfully used to measure salvianolic acid B, acetylsalicylic acid, and salicylic acid concentrations in human plasma samples from 16 patients to observe the pharmacokinetic changes caused by DDIs.…”
    Get full text
    Article
  19. 659

    Fabrication of taxifolin loaded zein-caseinate nanoparticles and its bioavailability in rat by Ying Li, Hang Su, Wenjun Wang, Zhongping Yin, Jing’en Li, En Yuan, Qingfeng Zhang

    Published 2023-11-01
    “…The dynamic variation of taxifolin and its metabolites in plasma were then quantified by UPLC with a triple-quadrupole typemass spectroscopy (UPLC-QqQ-MS/MS). A pharmacokinetic study showed that the bioavailability of taxifolin increased from 0.35 % to 0.52 % through TZP fabrication. …”
    Get full text
    Article
  20. 660

    Current Perspectives on Treatment of Gram-Positive Infections in India: What Is the Way Forward? by Atul P. Kulkarni, Vasant C. Nagvekar, Balaji Veeraraghavan, Anup R. Warrier, Deepak TS, Jaishid Ahdal, Rishi Jain

    Published 2019-01-01
    “…The most important step is development of newer antimicrobial agents with novel mechanisms of action and favourable pharmacokinetic profile. This review provides a synopsis about the current burden, treatment options, and the challenges faced by the clinicians in the management of GPIs such as MRSA, Quinolone-resistant Staphylococcus, VRE, and drug-resistant pneumococcus in India.…”
    Get full text
    Article